Artificial Intelligence in Medicine Market by Product Type (Hardware, Software, and Services), Technology (Deep Learning, Querying Method, Natural Language Processing, and Context Aware Processing), and Application (Drug Discovery & Repurposing, Clinical Research Trial, Personalized Medicine, and Others) - Global Opportunity Analysis and Industry Forecast, 2018-2025
- Published Date: 2020-10-18
- Report ID: 3146
- Pages: 231
-
Format:
The global artificial intelligence (AI) in medicine market was valued at $719 million in 2017 and is estimated to reach $18,119 million at a CAGR of 49.6% from 2018 to 2025. AI is an intelligent system that applies various human intelligence-based functions such as reasoning, learning, and problem-solving skills. AI technology uses software and different algorithms in the field of pharmaceuticals to support the decision-making processes for existing drugs and repurposing drugs to treat other conditions, along with accelerating the clinical trials process by finding the right patients from several data sources.
Shortage of skilled healthcare professionals and increase in the processing power of AI systems that is projected to help improve the efficiency of drug discovery and management of clinical trials majorly drive the growth of the global artificial intelligence in medicine market. Furthermore, the growth in importance of precision medicine and rise in funding of the R&D activities for the use of AI technology in the field of medicine are expected to fuel the market growth. However, limited acceptance from healthcare professionals and limitations of AI decision-making can impede the market growth. Untapped market opportunities available in developing regions such as India and China help to open new avenues for the growth of the artificial intelligence in medicine market in future.
The global artificial intelligence in medicine market is segmented based on product type, technology, application, and region. Based on product type, the market is segmented into hardware, software, and service. Based on technology, the market is classified into deep learning, querying method, natural language processing, and context aware processing. Based on application, the market is categorized into drug discovery & repurposing, clinical research trial, personalized medicine, and others. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY MARKET BENEFITS FOR STAKEHOLDERS
This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities.
Market estimations are based on comprehensive analysis of the key developments in the industry.
The global market is comprehensively analyzed with respect to product type, technology, application, and region.
In-depth analysis based on region assists to understand the regional market to help in strategic business planning.
The development strategies adopted by key manufacturers are enlisted to understand the competitive scenario of the market.
KEY MARKET SEGMENTS
By Product Type
Hardware
Software
Service
By Technology
Deep Learning
Querying Method
Natural Language Processing
Context Aware Processing
By Application
Drug Discovery & Repurposing (Preclinical Phase)
Clinical Research Trial
Personalized Medicine
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
United Kingdom
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Taiwan
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY PLAYERS PROFILED
Welltok, Inc.
Intel Corporation
Nvidia Corporation
Google Inc.
IBM Corporation
Microsoft Corporation
General Vision, Inc.
Enlitic, Inc.
BioXcel Corporation
Berg Health.
The other players of the artificial intelligence in medicine market include (companies not profiled in the report):
InSilico Medicine, Inc.
Globavir Biosciences, Inc.
GNS Healthcare
Flatiron Health
Benevolent AI
Atomwise
Verge Genomics
Cloud Pharmaceuticals
Recursion Pharmaceuticals
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porters five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in processing power of AI systems leading to enhanced AI capabilities
3.4.1.2. Dearth of skilled healthcare professionals
3.4.1.3. Growing importance of precision medicine
3.4.2. Restraints
3.4.2.1. Limitations of AI decision-making
3.4.2.2. Limited acceptance from healthcare professionals
3.4.3. Opportunities
3.4.3.1. Untapped market in developing regions
CHAPTER 4: ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Hardware
4.2.1. Key market trends, growth factors and growth opportunities
4.2.2. Market size and forecast
4.2.3. Market analysis, by country
4.3. Software
4.3.1. Key market trends, growth factors and growth opportunities
4.3.2. Market size and forecast
4.3.3. Market analysis, by country
4.4. Services
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast
4.4.3. Market analysis, by country
CHAPTER 5: ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY
5.1. Overview
5.1.1. Market size and forecast
5.2. Deep learning
5.2.1. Market size and forecast
5.2.2. Market analysis, by country
5.3. Querying method
5.3.1. Market size and forecast
5.3.2. Market analysis, by country
5.4. Natural language processing
5.4.1. Market size and forecast
5.4.2. Market analysis, by country
5.5. Context aware processing
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
CHAPTER 6: ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY APPLICATION
6.1. Overview
6.1.1. Market size and forecast
6.2. Drug Discovery
6.2.1. Market size and forecast
6.2.2. Market analysis, by country
6.3. Clinical Research Trial
6.3.1. Market size and forecast
6.3.2. Market analysis, by country
6.4. Personalized medicine
6.4.1. Market size and forecast
6.4.2. Market analysis, by country
6.5. Others
6.5.1. Market size and forecast
6.5.2. Market analysis, by country
CHAPTER 7: ARTIFICIAL INTELLIGENCE IN MEDICINE MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. North America market size and forecast, by product type
7.2.3. North America market size and forecast, by technology
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by country
7.2.5.1. U.S. market size and forecast, by product type
7.2.5.2. U.S. market size and forecast, by technology
7.2.5.3. U.S. market size and forecast, by application
7.2.5.4. Canada market size and forecast, by product type
7.2.5.5. Canada market size and forecast, by technology
7.2.5.6. Canada market size and forecast, by application
7.2.5.7. Mexico market size and forecast, by product type
7.2.5.8. Mexico market size and forecast, by technology
7.2.5.9. Mexico market size and forecast, by application
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Europe market size and forecast, by product type
7.3.3. Europe market size and forecast, by technology
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by country
7.3.5.1. Germany market size and forecast, by product type
7.3.5.2. Germany market size and forecast, by technology
7.3.5.3. Germany market size and forecast, by application
7.3.5.4. France market size and forecast, by product type
7.3.5.5. France market size and forecast, by technology
7.3.5.6. France market size and forecast, by application
7.3.5.7. UK market size and forecast, by product type
7.3.5.8. UK market size and forecast, by technology
7.3.5.9. UK market size and forecast, by application
7.3.5.10. Italy market size and forecast, by product type
7.3.5.11. Italy market size and forecast, by technology
7.3.5.12. Italy market size and forecast, by application
7.3.5.13. Spain market size and forecast, by product type
7.3.5.14. Spain market size and forecast, by technology
7.3.5.15. Spain market size and forecast, by application
7.3.5.16. Rest of Europe market size and forecast, by product type
7.3.5.17. Rest of Europe market size and forecast, by technology
7.3.5.18. Rest of Europe market size and forecast, by application
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Asia-Pacific market size and forecast, by product type
7.4.3. Asia-Pacific market size and forecast, by technology
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by country
7.4.5.1. Japan market size and forecast, by product type
7.4.5.2. Japan market size and forecast, by technology
7.4.5.3. Japan market size and forecast, by application
7.4.5.4. China market size and forecast, by product type
7.4.5.5. China market size and forecast, by technology
7.4.5.6. China market size and forecast, by application
7.4.5.7. Australia market size and forecast, by product type
7.4.5.8. Australia market size and forecast, by technology
7.4.5.9. Australia market size and forecast, by application
7.4.5.10. India market size and forecast, by product type
7.4.5.11. India market size and forecast, by technology
7.4.5.12. India market size and forecast, by application
7.4.5.13. South Korea market size and forecast, by product type
7.4.5.14. South Korea market size and forecast, by technology
7.4.5.15. South Korea market size and forecast, by application
7.4.5.16. Taiwan market size and forecast, by product type
7.4.5.17. Taiwan market size and forecast, by technology
7.4.5.18. Taiwan market size and forecast, by application
7.4.5.19. Rest of Asia-Pacific market size and forecast, by product type
7.4.5.20. Rest of Asia-Pacific market size and forecast, by technology
7.4.5.21. Rest of Asia-Pacific market size and forecast, by application
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. LAMEA market size and forecast, by product type
7.5.3. LAMEA market size and forecast, by technology
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by country
7.5.5.1. Brazil market size and forecast, by product type
7.5.5.2. Brazil market size and forecast, by technology
7.5.5.3. Brazil market size and forecast, by application
7.5.5.4. Saudi Arabia market size and forecast, by product type
7.5.5.5. Saudi Arabia market size and forecast, by technology
7.5.5.6. Saudi Arabia market size and forecast, by application
7.5.5.7. South Africa market size and forecast, by product type
7.5.5.8. South Africa market size and forecast, by technology
7.5.5.9. South Africa market size and forecast, by application
7.5.5.10. Rest of LAMEA market size and forecast, by product type
7.5.5.11. Rest of LAMEA market size and forecast, by technology
7.5.5.12. Rest of LAMEA market size and forecast, by application
CHAPTER 8: COMPANY PROFILES
8.1. Alphabet Inc. (Google Inc.)
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. Berg Health
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Product portfolio
8.2.4. Key strategic moves and developments
8.3. BioXcel Corporation
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Product portfolio
8.4. Enlitic Inc.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Product portfolio
8.4.4. Key strategic moves and developments
8.5. General Vision
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Key strategic moves and developments
8.6. IBM Corporation
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Intel Corporation
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. Microsoft Corporation
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Nvidia Corporation
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Business performance
8.9.6. Key strategic moves and developments
8.10. Welltok Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Key strategic moves and developments
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
